Aligning Science Across Parkinson's Logo Text
Submit site search
  • pHAGE-eGFP-OPTN E50K

    By on

    Plasmid

  • Time to LiD GWAS dataset

    By on

    Code to perform the study of LiD genetic determinants under CPH regression models and functional annotation analyses

  • Basal Ganglia Neurons in Healthy and Parkinsonian Primates Generate Recurring Sequences of Spikes

    By on

    Data consists of interspike intervals from basal ganglia neurons in awake monkeys, pre- and post-parkinsonian treatment with MPTP. Recordings were during spontaneous spiking, without task involvement.

  • x4 GBA Plasmids

    By on

    The below plasmids are deposited and available via Addgene:https://www.addgene.org/Anthony_Schapira/ . These have been used in publication: 10.1093/hmg/ddac233 188580 WT GBA pcDNA3.1 GBA (Homo sapiens) 188581 E326K GBA pcDNA3.1 GBA (Homo sapiens) 188582 L444P GBA pcDNA3.1 GBA (Homo sapiens) 188583 N370S GBA pcDNA3.1 GBA (Homo sapiens)

  • AAV viral DNA and whole RNA recovery for AAV pool experiments in rhesus macaque

    By on

    This protocol outlines procedures to extract viral DNA and whole RNA from rhesus macaque tissue that had been treated with AAV in vivo

  • Lentivirus plasmid: pLV[Exp]-U6>KAT8_P1_Seq1-hPGK>mApple

    By on

    Plasmid: Plasmid vector encoding a sgRNA sequence which targets the human KAT8 promoter for CRISPRi, under a U6 promoter and a mApple fluorescent reporter. Generated by Vectorbuilder in the pLV backbone.

  • pCAG-MBP-ATG9-D830A/E831A

    By on

    Plasmid for expression of human ATG9-D830A/E831A mutant in mammalian cells

  • cDNA synthesis

    By on

    Protocol for cDNA synthesis.

  • Structural basis for membrane recruitment of ATG16L1 by WIPI2 in Autophagy

    By on

    The authors showed through structural determination how ATG16L1 and WIPI2 interact and compared the other WIPI proteins showing the variety of mechanisms of membrane recruitment by WIPI proteins.

  • Expression and purification of mCherry-OPTN

    By on

    This protocol describes the purification of mCherry-OPTN.

  • pCMV-αS-2

    By on

    Mammalian expression of alpha-synuclein tandem dimer

  • pCAG- WIPI2dR125E- cs-TEV -STREP

    By on

    Plasmid: Mammalian expression of human WIPI2d R125E with C-terminal Strep

  • APEX-autophagy cargo receptor proteomics with and without lysosomal damage

    By on

    Proteomics data associated with DOI: 10.7554/eLife.72328

  • RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors

    By on

    The authors’ results reveal a mechanism by which pathogenic hyperactive LRRK2 may contribute to the altered synaptic homeostasis associated with characteristic non-motor and cognitive manifestations of PD.

  • pHAGE-APEX2-FLAG-CALCOCO2

    By on

    Plasmid

  • Catalepsy test (Bar test)

    By on

    The catalepsy test (bar test) was developed to test motor coordination and motor impairments.

  • Immunofluorescence staining

    By on

    This protocol describes the immunofluorescence staining of cells.

  • Brain Repair by Cell Replacement via In Situ Neuronal Reprogramming

    By on

    Neurodegenerative diseases, characterized by progressive neural loss, have been some of the most challenging medical problems in aging societies. Treatment strategies such as symptom management have little impact on disease progression, while intervention with specific disease mechanisms may only slow down disease progression. One therapeutic strategy that has the potential to reverse the disease phenotype is to replenish neurons and rebuild the pathway lost to degeneration. Although it is generally believed that the central nervous system has lost the capability to regenerate, increasing evidence indicates that the brain is more plastic than previously thought, containing perhaps the biggest repertoire of cells with latent neurogenic programs in the body. This review focuses on key advances in generating new neurons through in situ neuronal reprogramming, which is tied to fundamental questions regarding adult neurogenesis, cell source, and mechanisms for neuronal reprogramming, as well as the ability of new neurons to integrate into the existing circuitry.

  • Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia

    By on

    Genetic analysis of 3,964 PD cases revealed APOE-ϵ4 allele and new loci as risk factors for PD dementia progression, implicating amyloid pathway in PDD development and potential for amyloid-targeting therapy.

  • Analysis of glycosphingolipids from human plasma

    By on

    This is an updated protocol with the focus on achieving sensitive and reproducible quantitation of glycosphingolipids from human plasma samples

Load More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.